Adenovirus‐mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

No abstract is available for this paper.

• Publication year

  1996

• Venue

  International Journal of Cancer

• Publication date

  1996-09-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19960917)67:6<808::AID-IJC9>3.0.CO;2-VPMID 8824552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Karyotype analyses of 20 human glioma cell lines

  2005cited by this paper
• Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.

  1996cited by this paper
• Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption.

  1995cited by this paper
• Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas

  1995cited by this paper
• Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats.

  1995cited by this paper
• Purification of a Type 5 Recombinant Adenovirus Encoding Human p53 by Column Chromatography

  1995cited by this paper
• In Vivo Adenovirus-Mediated Gene Transfer of the Escherichia coli Cytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

  1995cited by this paper
• Interleukin-2 gene therapy in a patient with glioblastoma.

  1995cited by this paper
• Transfer of Genes to Humans: Early Lessons and Obstacles to Success

  1995cited by this paper
• The p53 Gene and Protein in Human Brain Tumors

  1994cited by this paper
• Human wild type p53 inhibits cell proliferation and elicits dramatic morphological changes in human glioma cell lines in vitro.

  1994cited by this paper
• Heterogeneity of subcellular localization of p53 protein in human glioblastomas.

  1994cited by this paper
• Adenovirus-mediated in vivo gene transfer into the central nervous system of a nonhuman primate (resident award paper).

  1994cited by this paper
• Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.

  1994cited by this paper
• Analysis of the p53 gene and its expression in human glioblastoma cells.

  1994cited by this paper
• The role of the p53 protein in the apoptotic response.

  1994cited by this paper
• Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of Cancer

  1994cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

  1994cited by this paper
• Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.

  1994cited by this paper
• p53-dependent apoptosis suppresses tumor growth and progression in vivo.

  1994cited by this paper
• An adenovirus vector for gene transfer into neurons and glia in the brain

  1993cited by this paper
• Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

  1993cited by this paper
• Detection of the initial stages of DNA fragmentation in apoptosis.

  1993cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1993cited by this paper
• Adenoviral vectors for gene transfer

  1993cited by this paper
• Stable Expression of the Wild-Type p53 Gene in Human Lung Cancer Cells after Retrovirus-Mediated Gene Transfer

  1993cited by this paper
• A model system for in vivo gene transfer into the central nervous system using an adenoviral vector

  1993cited by this paper
• Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors

  1993cited by this paper
• p53 and the Li-Fraumeni syndrome.

  1993cited by this paper
• Transfer of a foreign gene into the brain using adenovirus vectors

  1993cited by this paper
• p53 protein accumulation and gene mutations in human glioma cell lines

  1993cited by this paper
• In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

  1992cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• Clonal expansion of p53 mutant cells is associated with brain tumour progression

  1992cited by this paper
• Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

  1992cited by this paper
• p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.

  1992cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• TP53 Gene Mutations and 17p Deletions in Human Astrocytomas

  1991cited by this paper
• Timing and role of p53 gene mutation in the recurrence of glioma.

  1991cited by this paper
• Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

  1990cited by this paper
• Genetic mechanisms of tumor suppression by the human p53 gene

  1990cited by this paper
• Reoperation in the treatment of recurrent intracranial malignant gliomas.

  1987cited by this paper
• An enzyme-release assay for natural cytotoxicity.

  1983cited by this paper

• Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy

  2025cites this paper
• Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas

  2020cites this paper
• Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas

  2020cites this paper
• The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.

  2017cites this paper
• Modulation of Mammalian Cell Behavior for Enhancing Polymer-mediated Transgene Expression

  2016cites this paper
• Loss of Sparc in p 53‐null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival

  2015cites this paper
• TMPRSS2 promoter driven enzyme-prodrug therapy for the treatment of PCa

  2015cites this paper
• Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities.

  2014cites this paper
• Alterations in TP53 gene – Implications in Tumorigenesis Process and Prognosis in Central Nervous System Cancer

  2014cites this paper
• Gene therapy for malignant glioma

  2014cites this paper
• Advances in adenovirus-mediated p53 cancer gene therapy

  2013cites this paper
• C-JUN N-TERMINAL KINASES REGULATE ADENOVIRUS-MEDIATED AUTOPHAGY AND ANTIGEN PRESENTATION

  2013cites this paper
• Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils

  2012cites this paper
• 7 – Gene therapy for human brain tumors

  2012cites this paper
• Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr

  2011cites this paper
• Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53

  2011cites this paper
• Antiglioma effects of combined use of a baculovirual vector expressing wild‐type p53 and sodium butyrate

  2011cites this paper
• Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.

  2010cites this paper
• Experimental approaches for the treatment of malignant gliomas.

  2010cites this paper
• Adenoviral gene therapy in high-grade malignant glioma.

  2010cites this paper
• Emerging Treatment Modalities II: Gene Therapy for Meningiomas

  2009cites this paper
• Molecular fingerprinting of radiation resistant tumors: Can we apprehend and rehabilitate the suspects?

  2009cites this paper
• Hypoxia helps glioma to fight therapy.

  2009cites this paper
• Trichostatin A with adenovirus-mediated p53 gene transfer synergistically induces apoptosis in breast cancer cell line MDA-MB-231.

  2009cites this paper
• The Development of Targeted Cancer Gene-Therapy Adenoviruses for High-Grade Glioma Treatment

  2009cites this paper
• Evaluation of cytokine-transducing parvoviralvectors for glioma therapy

  2009cites this paper
• Genetic control of wayward pluripotent stem cells and their progeny after transplantation.

  2009cites this paper
• Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines

  2008cites this paper
• The inhibitor of growth (ING) gene family: potential role in cancer therapy.

  2008cites this paper
• Searching for a cure: Gene therapy for glioblastoma

  2008cites this paper
• Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells

  2007cites this paper
• Combination of Gene Therapy with Radiation

  2007cites this paper
• Novel Gene Therapeutic Approaches to Brain Cancer

  2006cites this paper
• Breast cancer gene therapy

  2006cites this paper
• Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one.

  2006cites this paper
• Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin

  2005cites this paper
• Chapter 14 – Gene Therapy for Malignant Gliomas

  2005cites this paper
• Functions of the Tumor Suppressor ING Family Genes

  2005cites this paper
• Mild hyperthermia plus adenoviral p53 over-expression additively inhibits the viability of human malignant glioma cells

  2005cites this paper
• Gene therapy and targeted toxins for glioma.

  2005cites this paper
• Gene therapy and targeted toxins for glioma.

  2005cites this paper
• Cancer-specific gene therapy.

  2005cites this paper
• Perspectives of Cellular and Molecular Neurosurgery.

  2004cites this paper
• Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with p53 gene transfer.

  2004cites this paper
• Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.

  2004cites this paper
• Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas.

  2004cites this paper
• High Expression of Aurora-B/Aurora and Ipl1-Like Midbody-Associated Protein (AIM-1) in Astrocytomas

  2004cites this paper
• Perspectives of Cellular and Molecular Neurosurgery

  2004cites this paper
• Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo.

  2004cites this paper
• Delivery systems and molecular targets of mechanism-based therapies for GBM

  2004cites this paper
• In vivo Recombinant Adenovirus-mediated p53 Gene Therapy in a Syngeneic Rat Model for Colorectal Cancer

  2004cites this paper
• Sensitizing glioma cells to cisplatin by abrogating the p53 response with antisense oligonucleotides

  2004cites this paper
• Gene Therapy with Virus Vectors for specific Disease of the Nervous System: The Principles Of Molecular Therapies For Glioblastoma

  2003cites this paper
• Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7.

  2003cites this paper
• Efficacy of adenoviral p53 delivery with SCH58500 in the intracranial 9l and RG2 models.

  2003cites this paper
• Current and Future Gene Therapy for Malignant Gliomas

  2003cites this paper
• The principles of molecular therapies for glioblastoma.

  2003cites this paper
• Gene therapy of gliomas.

  2003cites this paper
• Transcriptionally mediated gene targeting of gas1 to glioma cells elicits growth arrest and apoptosis

  2003cites this paper
• Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses

  2003cites this paper
• Genetic Markers in Glioblastoma: Prognostic Significance and Future Therapeutic Implications: On: Impact of Genotype Morphology on the Prognosis of Glioblastoma. Schmidt MC Antweiler S, Urban N, et al. J Neuropathol Exp Neurol 2002;61:321–328.

  2003cites this paper
• Phase I T rial o f A denovirus-Media ted p53 Gene T herapy f or Recurrent G lioma: B iological a nd C linical R esults

  2003cites this paper
• Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

  2003cites this paper
• Caspase-9 transduction overrides the resistance mechanism against p53-mediated apoptosis in U-87MG glioma cells.

  2002cites this paper
• Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.

  2002cites this paper
• Early gene therapy–induced apoptotic response in BT4C gliomas by magnetic resonance relaxation contrast T1 in the rotating frame

  2002cites this paper
• Cancer gene therapy: Part 2. Candidate transgenes and their clinical development.

  2002cites this paper
• Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.

  2002cites this paper
• Prostate cancer gene therapy and the role of radiation.

  2002cites this paper
• EFFICACY OF ADENOVIRAL P 53 DELIVERY WITH SCH 58500 IN THE INTRACRANIAL 9 L AND RG 2 MODELS

  2002cites this paper
• Cancer Gene Therapy with the p53 Tumor Suppressor Gene

  2002cites this paper
• Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas.

  2001cites this paper
• Preclinical Study of Adenoviral p53 Gene Therapy for Esophageal Cancer

  2001cites this paper
• Adenovirus cancer gene therapy

  2001cites this paper
• Gene therapy of glioblastomas: from suicide to homicide.

  2001cites this paper
• Caspase-9 Transduction Overrides the Resistance Mechanism against p53-mediated Apoptosis in U-87MG Glioma Cells

  2001cites this paper
• Growth-inhibitory effect of adenovirus-mediated p53 gene transfer on medulloblastoma cell line, Daoy, harboring mutant p53

  2001cites this paper
• Delivery of Cell Cycle Genes to Block Astrocytoma Growth

  2001cites this paper
• Intratumoral Spread and Increased Efficacy of a p53-VP22 Fusion Protein Expressed by a Recombinant Adenovirus

  2001cites this paper
• Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment.

  2001cites this paper
• Technology evaluation: Sch-58500, Canji.

  2000cites this paper
• Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor.

  2000cites this paper
• Degree of apoptosis induced by adenovirus-mediated transduction of p53 or p73alpha depends on the p53 status of glioma cells.

  2000cites this paper
• Clinical Protocol for p53 Gene Therapy for Liver Tumors.

  2000cites this paper
• Does p53 status influence tumor response to anticancer therapies?

  2000cites this paper
• Transduction of Apaf-1 or caspase-9 induces apoptosis in A-172 cells that are resistant to p53-mediated apoptosis.

  2000cites this paper
• Gene therapy for skull base tumors.

  2000cites this paper
• Retrovirus vector containing wild type p53 gene and its effect on human glioma cells.

  2000cites this paper
• Apoptosis in Glial Brain Tumors

  2000cites this paper
• Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacement.

  2000cites this paper
• Genetic Basis of Intramedullary Spinal Cord Tumors and Therapeutic Implications

  2000cites this paper
• Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts.

  2000cites this paper
• Potentials and limitations of adenovirus-p53 gene therapy for brain tumors.

  2000cites this paper
• Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53

  2000cites this paper
• Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy.

  2000cites this paper
• Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53

  2000cites this paper
• Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.

  1999cites this paper
• Combined radiation and p53 gene therapy of malignant glioma cells

  1999cites this paper
• Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule

  1999cites this paper
• Local control of gliomas: the next best step--a good step?

  1999cites this paper